Studies from the United States and South Korea have provided new prostate cancer data. Study 1: New research, "Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia," is the subject of a report. According to recent research from the United States, "The relationship between obesity and prostate cancer remains unclear. We investigated the effect of prostate volume on the obesity and prostate cancer association." "With a multi-centered, rapid-recruitment protocol, weight and body size measurements were collected prior to diagnosis, and medical charts were reviewed for pathology results (nB0 controls, 119 high-grade prostatic intraepithelial neoplasia (PIN) cases, an...

New investigation results, "History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study," are detailed in a study published in Cancer Causes and Control. According to recent research published in the journal Cancer Causes and Control, "A history of diabetes has been hypothesized to decrease prostate cancer risk, but studies have not always considered confounding or effect modification by dietary or lifestyle factors. We examined the association between diabetes history and subsequent prostate cancer risk in 328,316 men enrolled in the NIH-AARP Diet and Health Study." "Participants were ages 50-71 years and without a prostate cancer diagnosis at baseline in 1995. A prior history of physician-diag...

A novel method of drug delivery to inhibit the growth of prostate cancer cells has been developed by a doctoral candidate in pharmacy at the Hebrew University of Jerusalem. The student, Danny Goldstein, received the Barenholz Prize for Creativity and Originality in Applied Research for his work. The award, named for its donor, Yehezkel Barenholz, the Dr. Daniel G. Miller Professor of Cancer Research at the Hebrew University-Hadassah Medical School, was presented recently during the 70th meeting of the Hebrew University s Board of Governors. Prostate cancer is the second leading cause of cancer-related death for men in the U.S. Present treatments for metastatic prostate cancer (cancer cells that spread to other parts of the body) inclu...